Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study

Abstract Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in > 70 countries. Yet there is a shortage of data on this vaccine's performance in diverse populations. Here, we performed a prospective cohort study to assess the reactogenic...

Descrición completa

Detalles Bibliográficos

Principais autores:	Sergey Yegorov, Irina Kadyrova, Baurzhan Negmetzhanov, Yevgeniya Kolesnikova, Svetlana Kolesnichenko, Ilya Korshukov, Yeldar Baiken, Bakhyt Matkarimov, Matthew S. Miller, Gonzalo H. Hortelano, Dmitriy Babenko
Formato:	Artigo
Idioma:	Inglês
Publicado:	Nature Portfolio 2022-08-01
Series:	Scientific Reports
Acceso en liña:	https://doi.org/10.1038/s41598-022-17514-3
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!